Healthcare Services

Viral Inactivation Market Expected to Record Steady Growth and Approach $9.17 Billion by 2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Viral Inactivation Market Over The 2026–2030 Period?

The market size for viral inactivation has experienced rapid expansion in recent times. Projected figures indicate its expansion from $5.47 billion in 2025 to $6.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. Historically, this growth has been driven by factors such as the increasing production of plasma-derived products, the expansion of monoclonal antibody manufacturing, a heightened regulatory focus on viral safety, the growth in biopharmaceutical manufacturing capacity, and the broader acceptance of solvent detergent methods.

The viral inactivation market is projected to experience substantial growth in the coming years. It is expected to reach $9.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This anticipated expansion during the forecast period is driven by factors such as the increasing demand for biologics and biosimilars, rising investments in advanced bioprocessing facilities, a growing focus on continuous manufacturing, the increasing adoption of automated quality control systems, and the expansion of vaccine production pipelines. Key trends identified for this period include the increasing adoption of automated viral inactivation systems, a rising demand for validated virus safety processes, the growing use of continuous flow inactivation methods, the expansion of single-use bioprocessing solutions, and an enhanced focus on process reproducibility and compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What Underlying Factors Are Accelerating The Growth Of The Viral Inactivation Market?

The increasing occurrence of various infectious diseases is projected to drive the expansion of the viral inactivation market in the foreseeable future. Infectious diseases are conditions spread between individuals through contaminated food and drinks, or by pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation plays a crucial role in human disease control programs, utilizing physical and chemical disinfectants to neutralize viruses and curb the proliferation of contagious viral infections, thereby fueling the growth of the viral inactivation market. A notable example is the rise in tuberculosis cases: as reported by the Centers for Disease Control and Prevention in March 2024, cases in the United States escalated from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Concurrently, the rate grew from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Consequently, the rising prevalence of diverse infectious diseases is a significant factor propelling the growth of the viral inactivation market.

How Is The Viral Inactivation Market Segmented Across Key Categories?

The viral inactivation market covered in this report is segmented –

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

3) By Services: Viral Testing Services, Validation Services, Consulting Services

Which Upcoming Trends Are Expected To Influence The Viral Inactivation Market?

Leading companies operating within the viral inactivation market are focusing on integrating advanced viral-clearance technologies to enhance biologic safety, improve regulatory compliance, and boost process efficiency. These technologies, which inactivate viruses through chemical, physical, or filtration mechanisms, facilitate capabilities such as log-reduction validation, regulatory-compliant viral safety assurance, and more rapid decision-making in biologics development. For instance, in May 2025, Northway Biotech, a Lithuania-based contract development and manufacturing organization (CDMO), launched Full-Service Viral Clearance Studies (VCS). This advanced viral-clearance solution is designed to accelerate safety validation for protein biologics and gene therapies, featuring multiple identical BSL-2 laboratories for high-throughput workflows, BSL-3 testing capabilities, and providing full regulatory-compliant viral clearance results in under 10 weeks, a timeline significantly faster than industry norms. This offering improves development speed, enables better cost control, and enhances regulatory readiness for biopharma clients.

Who Are The Dominant Players Shaping The Viral Inactivation Market Landscape?

Major companies operating in the viral inactivation market are Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG

Read the full viral inactivation market report here:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Which Region Is Projected To Dominate The Viral Inactivation Market During The Forecast Period?

North America was the largest region in the viral inactivation market in 2025. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Inactivation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

Browse Through More Reports Similar to the Global Viral Inactivation Market 2026, By The Business Research Company

Oral Expectorant Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Antivirals Global Market Report

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Viral And Non Viral Vector Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795